UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Horan Capital Advisors LLC.

Horan Capital Advisors LLC. lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 34.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 691 shares of the healthcare conglomerate’s stock after selling 365 shares during the quarter. Horan Capital Advisors LLC.’s holdings in UnitedHealth Group were worth $350,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Alley Investment Management Company LLC boosted its position in UnitedHealth Group by 0.5% in the fourth quarter. Alley Investment Management Company LLC now owns 15,501 shares of the healthcare conglomerate’s stock valued at $7,842,000 after buying an additional 81 shares during the last quarter. Ariston Services Group boosted its position in UnitedHealth Group by 15.0% in the fourth quarter. Ariston Services Group now owns 705 shares of the healthcare conglomerate’s stock valued at $357,000 after buying an additional 92 shares during the last quarter. Ring Mountain Capital LLC purchased a new stake in UnitedHealth Group in the fourth quarter valued at approximately $408,000. Synergy Investment Management LLC purchased a new stake in UnitedHealth Group in the fourth quarter valued at approximately $896,000. Finally, Patten Group Inc. boosted its position in UnitedHealth Group by 5.0% in the fourth quarter. Patten Group Inc. now owns 5,961 shares of the healthcare conglomerate’s stock valued at $3,015,000 after buying an additional 282 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 0.33% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the topic of several recent research reports. Oppenheimer upped their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Truist Financial lowered their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Deutsche Bank Aktiengesellschaft upped their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Finally, StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Stock Down 1.6 %

Shares of NYSE:UNH opened at $467.21 on Tuesday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The business has a fifty day moving average of $515.81 and a two-hundred day moving average of $556.09. The stock has a market cap of $429.97 billion, a P/E ratio of 30.14, a PEG ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the business earned $5.83 EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.80%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.